搜索临床试验以:Selumetinib Docetaxel
总计2353个结果
-
University of Alabama at BirminghamChildren's Hospital of Philadelphia; Congressionally Directed Medical Research Programs尚未招聘神经纤维瘤病 1 | 丛状神经纤维瘤
-
AstraZeneca终止
-
Haihe Biopharma Co., Ltd.未知
-
Shanghai Junshi Bioscience Co., Ltd.招聘中
-
GERCOR - Multidisciplinary Oncology Cooperative...AstraZeneca主动,不招人
-
Queen Mary University of LondonAstraZeneca; Cancer Research UK未知鳞状细胞肺癌 | 三阴性乳腺癌 | 具有 KRAS 突变的非鳞状细胞肺癌 | 具有野生型 KRAS 的非鳞状细胞肺癌英国
-
National Cancer Institute (NCI)主动,不招人转移性黑色素瘤 | IV 期皮肤黑色素瘤 AJCC v6 和 v7 | 难治性恶性实体瘤 | 不可切除的恶性实体肿瘤美国
-
University of Alabama at BirminghamUnited States Department of Defense尚未招聘
-
National Cancer Institute (NCI)撤销晚期成人原发性肝癌 | 局部不可切除的成人原发性肝癌 | 复发性成人原发性肝癌 | 复发性肝外胆管癌 | 不可切除的肝外胆管癌 | II期胆囊癌 | IIIA期胆囊癌 | IIIB期胆囊癌 | IVA 期胆囊癌 | IVB 期胆囊癌 | 肝外胆管胆管癌 | 胆囊腺癌 | 腺癌伴胆囊鳞状化生 | 成人原发性胆管细胞癌 | 转移性肝外胆管癌
-
National Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterAstraZeneca; MedImmune LLC撤销呼吸道和胸腔内器官恶性肿瘤 | 晚期肺癌 | Recurrent Nonsmall Cell Lung Cancer
-
National Cancer Institute (NCI)终止复发性黑色素瘤 | IV 期黑色素瘤 | IIIA期黑色素瘤 | IIIB期黑色素瘤 | IIIC期黑色素瘤美国
-
Nereus Pharmaceuticals, Inc.完全的
-
National Cancer Institute (NCI)主动,不招人低级别胶质瘤 | 复发性视觉通路神经胶质瘤 | 难治性视觉通路胶质瘤 | 复发性儿童毛细胞星形细胞瘤 | 复发性神经纤维瘤病 1 型 | 难治性神经纤维瘤病 1 型美国
-
AstraZeneca完全的黑色素瘤 | 乳腺癌 | 大肠癌 | 胰腺癌 | 肺癌 | 头颈癌 | 胆道癌 | 胃食管癌美国
-
Tianjin Medical University Cancer Institute and...招聘中
-
National Cancer Center, KoreaSeoul National University Bundang Hospital; Gachon University Gil Medical Center; Chungbuk National...未知
-
Academy Military Medical Science, ChinaCancer Institute and Hospital, Chinese Academy of Medical Sciences未知
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, China完全的
-
Merck Sharp & Dohme LLC完全的
-
National Cancer Institute (NCI)完全的复发性甲状腺癌 | I期甲状腺乳头状癌 | II期甲状腺乳头状癌 | III 期甲状腺乳头状癌 | IV 期甲状腺乳头状癌美国, 加拿大
-
Boehringer Ingelheim完全的
-
Russian Academy of Medical SciencesRussian Society of Clinical Oncology未知
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer Network主动,不招人
-
University of BirminghamPfizer; AstraZeneca; Mirati Therapeutics Inc.; Cancer Research UK; Experimental Cancer Medicine Centres主动,不招人
-
Hunan Cancer HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.; Hunan Provincial People's Hospital未知
-
Seoul National University HospitalClinical Research Center for Solid Tumor, Korea终止
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, China终止
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, Australia招聘中
-
Cristal Therapeutics完全的
-
University Health Network, Toronto主动,不招人
-
AstraZeneca完全的葡萄膜黑色素瘤 | 转移性美国, 捷克共和国, 西班牙, 英国, 德国, 加拿大, 以色列, 荷兰, 比利时, 法国, 芬兰